These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10100758)

  • 1. Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.
    Erbersdobler A; Friedrich MG; Schwaibold H; Henke RP; Huland H
    Oncol Res; 1998; 10(8):415-20. PubMed ID: 10100758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.
    Turyn J; Matuszewski M; Schlichtholz B
    Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular serological diagnosis in transitional cell bladder cancer.
    von Knobloch R; Brandt H; Hofmann R
    Ann N Y Acad Sci; 2004 Jun; 1022():70-5. PubMed ID: 15251942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
    Paterson RF; Ulbright TM; MacLennan GT; Zhang S; Pan CX; Sweeney CJ; Moore CR; Foster RS; Koch MO; Eble JN; Cheng L
    Cancer; 2003 Nov; 98(9):1830-6. PubMed ID: 14584063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.
    Olumi AF; Tsai YC; Nichols PW; Skinner DG; Cain DR; Bender LI; Jones PA
    Cancer Res; 1990 Nov; 50(21):7081-3. PubMed ID: 2208176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelotype of human bladder cancer.
    Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG
    Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Mess F; Böhle A; Feller AC
    Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability as prognostic marker in bladder tumors: a clinical significance.
    Vaish M; Mandhani A; Mittal RD; Mittal B
    BMC Urol; 2005 Jan; 5():2. PubMed ID: 15647110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors.
    Orlow I; Lianes P; Lacombe L; Dalbagni G; Reuter VE; Cordon-Cardo C
    Cancer Res; 1994 Jun; 54(11):2848-51. PubMed ID: 8187066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade.
    Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G
    Clin Cancer Res; 2000 Feb; 6(2):610-5. PubMed ID: 10690546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
    Edwards J; Duncan P; Going JJ; Grigor KM; Watters AD; Bartlett JM
    Br J Cancer; 2001 Dec; 85(12):1894-9. PubMed ID: 11747332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
    Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA
    Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.
    Simoneau M; LaRue H; Aboulkassim TO; Meyer F; Moore L; Fradet Y
    Oncogene; 2000 Dec; 19(54):6317-23. PubMed ID: 11175346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
    Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
    Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of polymerase chain reaction analysis of urinary DNA to detect bladder carcinoma.
    Little B; Hughes A; Young MR; O'Brien A
    Urol Oncol; 2005; 23(2):102-7. PubMed ID: 15869994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitional cell bladder tumor: predicting recurrence and progression by analysis of microsatellite loss of heterozygosity in urine sediment and tumor tissue.
    Fornari D; Steven K; Hansen AB; Jepsen JV; Poulsen AL; Vibits H; Horn T
    Cancer Genet Cytogenet; 2006 May; 167(1):15-9. PubMed ID: 16682280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
    Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
    J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.